Administration of a Next-Generation Probiotic <i>Escherichia coli</i> Nissle 1917-GLP-1 Alleviates Diabetes in Mice With Type 1 and Type 2 Diabetes.

Starting from the third week, the levels of fasting blood glucose in mice receiving EcN-GLP-1 treatment showed a decreasing trend and were notably lower compared to the M group (21.0 mmol/L versus 24.7 mmol/L, p < 0.01) ( Figure 4(b) ).

also in 27,535 other papers